Lv1
8 积分 2025-09-24 加入
Integrating WGCNA and machine learning to identify and validate key biomarkers in MASLD
1个月前
已完结
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
1个月前
已完结
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
1个月前
已完结
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
1个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
1个月前
已完结
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
1个月前
已完结
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
1个月前
已完结
Mechanism study of phthalate exposure promoting endometriosis: Based on the ferroptosis perspective
2个月前
已完结
Metabolic Dysfunction-Associated Steatohepatitis in Focus: Pathogenesis, Non-Invasive Diagnostics, and Future Approaches
2个月前
已完结
Identification of modifiable plasma protein markers of cardiometabolic risk in children and adolescents with obesity
3个月前
已关闭
皖公网安备34019202002308
